Immunoassay Analyzers Market Trends
The global immunoassay analyzers market size was valued at USD 7.61 billion in 2023 and is projected to grow at a CAGR of 3.2% from 2024 to 2030. An increase in incidences of chronic diseases, such as infectious and noninfectious diseases, is the primary factor driving the market growth. Technological innovations and applications of immunoassay are rapidly expanding due to diseases such as cancer and cardiology.The rise in the number of chronic and infectious diseases is a leading cause of market growth for immunoassay analyzers. The rising number of cardiology and cancer cases is contributing to the development of new and advanced treatment options, and companies are innovating new treatments. The WHO reported 20 million new cases of cancer in 2022 and has projected the estimated number of cancer diagnoses to 53.5 million.
During the outbreak of the COVID-19 pandemic, the SARS-CoV-2 virus created an urgent need for an accelerated diagnosis, promising precision and affordability combined in one method. RT-PCR tests were conducted for early diagnosis but were considered an expensive approach. That drove immunoassay analyzers to be deployed to detect antibodies for quick and cost-effective methods. For instance, Agilent Technologies, Inc. launched Agilent Dako SARS-CoV-2, an enzyme-linked immunoassay kit to detect SARS-CoV-2 antibodies in human serum or plasma. The pandemic brought awareness of immunoassay analyzers in the market and accelerated technological developments.
The rise in chronic diseases has led to technological advancements in immunoassay analyzers. Emerging diseases, antibiotic resistance, and the demand for personalized medicine drive the advancements of sensitive, specific, and rapid immunoassay tests. Various companies are coming up with technological solutions to fulfill this demand for treatment. For instance, Diamond Diagnostics is ensuring healthcare providers access to advanced immunoassay diagnostics through the manufacturing of high-quality and cost-effective consumables and accessories products of immunoassay analyzers. Such innovations are expected to drive market growth.
The rise in collaboration activities of various companies is another driving factor for market growth. For instance, Beckman Coulter, Inc. and Fujirebio partnered in July 2023 to strengthen respective immunoassay capabilities to support therapeutic advancement, clinical trials, routine clinical adoption, and reimbursement in neurodegenerative diseases. Such partnerships are driving the market growth of immunoassay analyzers.
Global Immunoassay Analyzers Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global immunoassay analyzers market report based on product, application, end use, and region:- Product Outlook (Revenue, USD Million, 2018 - 2030)
- Chemiluminescence Immunoassay (CLIA)
- Fluorescence Immunoassay (FIA)
- Radioimmunoassay
- Enzyme-Linked Immunoassay
- Consumables and Accessories
- Application Outlook (Revenue, USD Million, 2018 - 2030)
- Therapeutic Drug Monitoring
- Oncology
- Cardiology
- Endocrinology
- Infectious Disease Testing
- Autoimmune Disease
- Others
- End Use Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Diagnostic Laboratories
- Research Institutes
- Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Latin America
- Brazil
- Middle East and Africa (MEA)
- KSA
- UAE
- South Africa
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Immunoassay Analyzers Market Variables, Trends, & Scope
Chapter 4. Immunoassay Analyzers Market: Product Estimates & Trend Analysis
Chapter 5. Immunoassay Analyzers Market: Application Estimates & Trend Analysis
Chapter 6. Immunoassay Analyzers Market: End Use Estimates & Trend Analysis
Chapter 7. Immunoassay Analyzers Market: Regional Estimates & Trend Analysis
Chapter 8. Competitive Landscape
Companies Mentioned
- Siemens Healthineers AG
- BIOMÉRIEUX
- Abbott
- QuidelOrtho Corporation
- Sysmex Corporation
- BD
- Thermo Fisher Scientific Inc.
- F. Hoffmann-La Roche Ltd
- Beckman Coulter, Inc.
- DiaSorin S.p.A.
Methodology
LOADING...
